Skip to main content

Table 2 Liver function parameters before and 1 month after the procedure

From: Safety and efficacy of self-expandable metallic stent combined with 125I brachytherapy for the treatment of malignant obstructive jaundice

Parameters

All

(n=59)

Brachytherapy group

(n=34)

Control group

(n=25)

P value

ALT (U/L)

 Before

57.58±26.66

60.51±25.58

53.60±28.09

0.329

 After

44.71±16.64

46.97±16.36

41.62±16.85

0.226

P value

 

0.002*

0.004*

 

AST (U/L)

 Before

68.87±33.10

65.57±30.74

73.35±36.22

0.377

 After

46.66±19.84

45.59±21.22

48.10±18.13

0.635

P value

 

0.000*

0.000*

 

TBIL (μmol/L)

 Before

324.47±186.75

305.18±194.12

350.71±176.69

0.359

 After

65.07±31.09

61.93±33.48

69.34±27.60

0.370

P value

 

0.000*

0.000*

 

DBIL (μmol/L)

 Before

260.93±142.22

247.43±152.21

279.29±128.12

0.400

 After

54.19±27.41

51.02±29.38

58.50±24.40

0.304

P value

 

0.000*

0.000*

 
  1. Liver function parameters including ALT, AST, TBIL, and DBIL decreased significantly from before to 1 month after the procedure, * p value ≤ 0.05 was considered to indicate statistical significance
  2. ALT Alanine aminotransferase, AST Aspartate aminotransferase, TBIL Total bilirubin, DBIL direct bilirubin